Chelsea Green Pharmacy
Choosing the right weight loss medication can feel overwhelming when two of the most talked-about options, Mounjaro and Wegovy, both promise significant results. Both have shown impressive outcomes in helping people reach their weight loss goals, but they work differently, are dosed differently, and suit different people depending on their health background and goals. At our Chelsea clinic, we help patients weigh up weight loss medication options properly, rather than choosing based on which one is trending online.
If you are trying to decide between Mounjaro and Wegovy, or wondering whether to switch from one to the other, this guide walks through the key differences step by step. Contact our team or book a consultation at our Chelsea clinic to discuss which option may suit you.
Quick Answer
Mounjaro (tirzepatide) targets two hormone pathways, GLP-1 and GIP, and may lead to slightly greater weight loss for some patients. As an alternative, Wegovy (semaglutide) targets GLP-1 alone and is specifically licensed for chronic weight management. Both are weekly injections with similar side effect profiles. The right choice depends on your health goals, medical history, and how your body responds, which is why a proper consultation matters more than comparing headline statistics alone.
Step 1: Understand The Medications
Before choosing between Mounjaro and Wegovy, it is essential to understand how each works.
Mounjaro (tirzepatide) is a dual-acting medication originally developed for type 2 diabetes. It activates two key receptors in the body, GLP-1 and GIP. By targeting these pathways, Mounjaro helps regulate appetite, improve blood sugar control, and reduce body weight.
Wegovy (semaglutide) is a GLP-1 receptor agonist specifically approved for chronic weight management. It works by mimicking a hormone in the gut that helps regulate appetite and calorie intake.
While both medications promote weight loss, Mounjaro’s dual mechanism may offer additional benefits for certain individuals, particularly those with metabolic disorders.
Mounjaro vs Wegovy: A Quick Comparison
| Feature | Mounjaro (Tirzepatide) | Wegovy (Semaglutide) |
|---|---|---|
| Mechanism | Dual action: GLP-1 and GIP | Single action: GLP-1 only |
| Primary licensed use | Type 2 diabetes and weight management | Chronic weight management |
| Administration | Weekly subcutaneous injection | Weekly subcutaneous injection |
| Starting dose | Usually 2.5mg, titrated upward | Low starting dose, gradually increased |
| Common side effects | Nausea, vomiting, gastrointestinal discomfort | Nausea, mild constipation |
Step 2: Consider Your Health Goals
Your primary health goal will play a significant role in deciding between these medications.
- If you are managing type 2 diabetes and weight loss is a secondary goal, Mounjaro may be the better choice as it addresses both blood sugar control and weight management
- If your main focus is chronic weight management, especially if you do not have diabetes, Wegovy is specifically designed for this purpose and may be more suitable
Step 3: Assess Your Medical History
Your personal medical history is another critical factor to consider. For example:
- If you have a history of pancreatitis, thyroid cancer, or severe gastrointestinal issues, both medications may require caution. Consult your healthcare provider to evaluate risks
- Individuals with a strong family history of metabolic conditions may benefit more from Mounjaro’s dual-action approach

Step 4: Understand The Side Effects
Both medications share some common side effects, including nausea, vomiting, and gastrointestinal discomfort. However, they can vary slightly in severity and frequency.
Mounjaro may have a slightly higher incidence of gastrointestinal side effects due to its dual mechanism of action.
Wegovy is more typically associated with side effects like nausea and mild constipation, which tend to subside as your body adjusts.
If side effects are a concern, discussing management strategies with your doctor can help.
Step 5: Review The Dosage And Administration
Both medications are administered via weekly injections, but there are differences.
Mounjaro is available in a range of doses, with flexibility for titration based on individual tolerance and response.
Wegovy starts with a low dose to minimise side effects and gradually increases to the target dose over several months.
Your comfort with the dosing schedule and adjustments may influence your choice.
Which Is Easier To Use? Comparing Practicalities For At-Home Use
Beyond how each medication works clinically, many patients care just as much about how easy a treatment is to fit into daily life. Since both Mounjaro and Wegovy are self-administered at home, practical differences can genuinely affect which one suits you better.
| Practical Factor | Mounjaro | Wegovy |
|---|---|---|
| Injection frequency | Once weekly | Once weekly |
| Pen device | Pre-filled pen, single-use | Pre-filled pen, single-use |
| Storage | Refrigerated until first use | Refrigerated until first use |
| Dose adjustment | Multiple dose strengths for flexible titration | Structured dose schedule over several months |
| Injection sites | Abdomen, thigh, or upper arm | Abdomen, thigh, or upper arm |
In practice, both pens are designed to be straightforward for home use, with similar injection technique, storage requirements, and site rotation needed. Neither requires drawing medication from a vial, which makes both considerably easier to manage at home compared with older insulin-style pens. The main practical difference tends to come down to personal comfort with the specific pen device and how each person’s body responds to the titration schedule, rather than one being objectively easier than the other.
Step 6: Compare Effectiveness
While both medications are effective for weight loss, recent studies suggest that Mounjaro may lead to slightly higher weight loss in certain populations compared to Wegovy. However, individual responses vary, and what works best for one person may not be ideal for another.

When Wegovy Plateaus: What Is Going On?
Wegovy has shown excellent results for many people. It works by mimicking GLP-1, a naturally occurring hormone that regulates appetite and blood sugar. For most patients, this leads to a significant reduction in hunger and calorie intake, which can support weight loss over time.
However, for some individuals:
- Weight loss may plateau after several months
- Side effects such as nausea, fatigue, or constipation become bothersome
- The appetite-suppressing effect may wear off slightly
- Progress slows despite maintaining lifestyle changes
These experiences are entirely normal, but they may also signal it is time to review your medication with a professional.
Why Consider Switching From Wegovy To Mounjaro?
Here are a few reasons why patients at our clinic have made the switch:
You Have Plateaued
If your weight loss has stalled for six or more weeks despite adherence, Mounjaro’s dual-action mechanism may provide an extra push.
You Want Greater Appetite Control
Some patients find that Mounjaro provides stronger hunger suppression, especially in the evening or between meals.
You Struggled With Wegovy’s Side Effects
Although both medications can cause nausea or digestive symptoms, some patients tolerate tirzepatide better. The side effect profile can differ based on your body’s response.
You Have Type 2 Diabetes
Mounjaro is also used to manage blood sugar, so it may be an excellent option if you have coexisting metabolic conditions, particularly type 2 diabetes.
Is It Safe To Switch Between Medications?
Switching from Wegovy to Mounjaro should always be done under the guidance of a healthcare professional. At our clinic, we offer one-to-one consultations to:
- Review your current medication and dosing history
- Assess your progress, side effects, and goals
- Provide a safe and structured plan for switching to Mounjaro, if appropriate
- Monitor your response, dosage adjustments, and wellbeing over time
You should never stop or change your medication without consulting a pharmacist or prescriber, especially with injectable treatments.
What To Expect When Starting Mounjaro
Mounjaro is taken once a week by subcutaneous injection, just like Wegovy. It begins at a low dose (usually 2.5mg) and gradually increases over time, based on tolerability and response.
During the first few weeks:
- You may experience mild nausea or reduced appetite
- Your hunger cues may change significantly
- You should follow a balanced, protein-rich diet and stay hydrated
- Regular check-ins with our pharmacy team are important to assess your progress and comfort
Many patients report feeling “in control” of their eating habits again, often with fewer cravings or emotional triggers.
Curious What Your Own Results Might Look Like?
Every person’s response to Mounjaro or Wegovy depends on their starting point, dose, and consistency. Use the calculator below to get a general sense of what realistic progress might look like before your consultation.
This tool offers general estimates only. Your actual results depend on your individual health, dose, and consistency, which is exactly what we assess during a consultation.
Step 7: Factor In Cost And Accessibility
Cost can be a deciding factor when comparing Mounjaro vs Wegovy. Both medications are relatively expensive, and availability can vary based on location and prescription coverage. Check with your pharmacy or healthcare provider about pricing and options.

Step 8: Consult A Healthcare Professional
Ultimately, the best way to decide between Mounjaro and Wegovy is by consulting a qualified healthcare professional. They can assess your health needs, review your medical history, and recommend the most suitable option.
According to the NHS, medication is most effective as part of a wider approach to weight management that includes dietary changes and physical activity, rather than being relied upon in isolation, whichever treatment you choose.
Frequently Asked Questions
Choosing or switching between these medications often raises further questions beyond the basics. Here are some of the ones we hear most often at our Chelsea clinic.
Can I switch directly from Wegovy to Mounjaro, or does my body need a break in between?
This depends on your individual circumstances, including your current dose and how your body has responded to treatment so far. A clinician will typically assess your last Wegovy dose and timing before recommending a starting Mounjaro dose, rather than applying a fixed washout period to everyone. This is exactly why switching should always be planned through a consultation rather than done independently.
Will I need to restart the dose titration process from the beginning if I switch?
In most cases, yes, Mounjaro’s dosing schedule is separate from Wegovy’s, so you will generally begin at a low starting dose and titrate upward again, regardless of the dose you had reached on Wegovy. This allows your body to adjust safely to the new medication rather than assuming tolerance carries across between the two.
Is one medication generally considered more suitable for long-term, ongoing use?
Both medications are used for long-term weight management under medical supervision, and neither is inherently more or less suitable for ongoing use than the other. The right choice for long-term treatment depends on how well you tolerate the medication, your response over time, and any changes in your health, which is why regular reviews matter more than picking one option and assuming it will remain ideal indefinitely.
Can I try Mounjaro first without ever having taken Wegovy?
Yes, there is no requirement to try Wegovy before starting Mounjaro. Some patients choose Mounjaro as their first treatment based on their health goals, particularly if they have type 2 diabetes or a strong family history of metabolic conditions. Your consultation will assess which medication is the more suitable starting point for you specifically.
Does needing a higher dose over time mean the medication is not working?
Not at all. Dose increases on both Mounjaro and Wegovy are a planned part of treatment, designed to gradually build up to an effective and well-tolerated level rather than a sign of failure. Titration schedules exist specifically to minimise side effects while still reaching a dose that supports meaningful results.
Are there any patients who should avoid both Mounjaro and Wegovy entirely?
Yes. Those with a personal or family history of certain thyroid cancers, a history of pancreatitis, or specific gastrointestinal conditions may not be suitable candidates for either medication. This is precisely why a thorough medical history review is a core part of any consultation, rather than a formality, before either treatment is prescribed.
Where can I get a consultation to compare Mounjaro and Wegovy in Chelsea?
Our clinic is based at 6 Elystan Street, Chelsea, London, SW3 3NS, and offers confidential, pharmacy-led consultations to assess your suitability for either medication, or to review a potential switch. You can book directly through our website or by calling 0207 584 5424.
Conclusion: Mounjaro vs Wegovy
Choosing between Mounjaro and Wegovy depends on several factors, including your health goals, medical history, and personal preferences. While Mounjaro’s dual-action approach may appeal to those with diabetes or metabolic challenges, Wegovy’s focus on chronic weight management makes it ideal for individuals aiming for long-term weight loss.
At the end of the day, both medications offer significant benefits, and the right choice will depend on your unique circumstances. Take the first step towards a healthier you by contacting us about which medication is best for your weight loss journey.

☑ Clinically Reviewed
A pharmacist reviews the content to help ensure medicines are presented responsibly and that patient-facing health information is accurate, appropriate, and aligned with current clinical guidance.
Last reviewed: September 2026